RBN-3143
RBN-3143 is a potent inhibitor of NAD+-competitive catalytic PARP14 (IC50= 4 nM), which inhibits ADP-ribosylation mediated by PARP14 and stabilizes PARP14 in cell lines, demonstrating research potential for lung inflammation.
Product Specifications
CAS Number
2360853-16-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
449.54
Molecular Formula
C22H28FN3O4S
Notes
Research use only, not for human use.
Receptor
PARP
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
035344-ML550 100 µL
FAHD2A, CT (FAHD2A, Fumarylacetoacetate hydrolase domain-containing protein 2A) (MaxLight 550) discontinued
Ask
View Details 
MBS6352561-01 0.1 mL
SUMO1 (SUMO1, SMT3C, SMT3H3, UBL1, Small ubiquitin-related modifier 1, GAP-modifying protein 1, SMT3 homolog 3, Sentrin, Ubiquitin-homology domain protein PIC1, Ubiquitin-like protein SMT3C, Ubiquitin-like protein UBL1) (MaxLight 490)
Ask
View Details 
MBS6352561-02 5x 0.1 mL
SUMO1 (SUMO1, SMT3C, SMT3H3, UBL1, Small ubiquitin-related modifier 1, GAP-modifying protein 1, SMT3 homolog 3, Sentrin, Ubiquitin-homology domain protein PIC1, Ubiquitin-like protein SMT3C, Ubiquitin-like protein UBL1) (MaxLight 490)
Ask
View Details